Home › Studies › PRJNA321058
PRJNA321058 SRP075633

FMT for active Crohn's disease, USA, open-label study

Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease

53 stool samples from USA patients with Crohn's disease, collected before and after a single fecal microbiota transplant from healthy donors via colonoscopy, in an uncontrolled, prospective open-label study. machine-written summary

53 samples · 53 runs · US · Age unknown · 2016 · 4.66 Gbp / sample

Sources
✓Sequence archive 253✓Abstract / description 8○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive253 sample values (country, health condition, health condition detail, subject id, timepoint)
✓ Abstract / description8 sample values (health condition, health condition detail)
○ Full textread; no usable statement or table · PMC11009399, PMC12180181, PMC12239758, PMC12268991, PMC12940132, PMC6759048, PMC7248251
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Faecal microbiota transplantation design single_arm_before_after · population crohns_disease · Single FMT via colonoscopy from healthy donors to active CD patients

“A single FMT was performed via colonoscopy” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
unknown53
Condition
crohns_disease53
Country
US53
Body site
primary53
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 1 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 8 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 44 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.66 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinalFMT donor → recipient — not resolved

18 of 22 people sampled more than once (49 samples; median 3, up to 3 per person) · follow-up median 28 d (max 28 d) · median interval between samples 28 d (time from timepoint labels). Schedule stated by the source: “Stool collected pre-FMT, 4 weeks after FMT, and 8 weeks after FMT in recipients; clinical follow-up 12 weeks, safety follow-up 26 weeks.” (time origin: FMT); stated follow-up 6 mo.

R1003R1003: day 0R1003: day 28R1008R1008: day 0R1008: day 28R1012R1012: day 0R1012: day 280 d7 d14 d21 d28 d

Each row is one person (3 shown of 18); dots are samples at days since that person's first sample.

FMT from healthy donors (D9001-D9005) to Crohn's disease recipients (R1001-R1022); donor->recipient mapping not in metadata.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 17.9%Phocaeicola 12.4%Faecalibacterium 11.4%Prevotella 10.9%Alistipes 4.3%Roseburia 4.0%Parabacteroides 2.3%Enterococcus_B 1.8%Enterocloster 1.3%Dialister 1.3%Cryptobacteroides 1.3%Lachnospira 1.1%not assigned to a genus 7.0%other genera 23.0%

Genera, mean relative abundance over 49 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country53 100%53
health_condition53 100%494
subject_id53 100%53
health_condition_detail53 100%494
timepoint_label49 92%49
Papers (8)
  • Impact of Microbiota Transplant on Resistome of Gut Microbiota in Gnotobiotic Piglets and Human Subjects. 2020 PMID 32508773 PMC7248251 own_data
  • Microbial genes and pathways in inflammatory bowel disease. 2019 PMID 31249397 PMC6759048 unsure
  • Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases. 2024 PMID 38605009 PMC11009399 unsure
  • A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules. 2025 PMID 39947133 PMC12268991 unsure
  • Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation. 2025 PMID 40542451 PMC12180181 unsure
3 more
  • Constructing inflammatory bowel disease diagnostic models based on k-mer and machine learning. 2025 PMID 40636504 PMC12239758
  • Temporal dynamics of gut biosynthetic gene clusters link persistent colonization and engraftment in fecal microbiota transplantation. 2026 PMID 41741396 PMC12940132
  • Plasmid dispersal and recombination across human gut microbiomes is neutral, but overpowered by inflammatory diseases 2023
Details
Archive description

This is an uncontrolled, prospective open-label study of FMT from healthy donors to subjects with active CD. A single FMT was performed via colonoscopy. Stool samples were collected prior to FMT and at two time points, four and eight weeks after FMT. Recipients’ microbial diversity, mucosal T-cell phenotypes and clinical and inflammatory parameters were measured over 12 weeks, and safety over 26 weeks.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.85. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site study.description · “Stool samples were collected prior to FMT”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN05065727countryUSR10.90sample.attr.geo_loc_nameUSA
SAMN05065727health_conditioncrohns_diseaseR10.85biosample.attribute:gastroinstest_disordgastroinstest_disord: Crohn's disease
SAMN05065738health_conditioncrohns_diseaseR40.50study.descriptionsubjects with active CD
SAMN05065727health_condition_detailCrohn's diseaseR10.90sample.attr.gastroinstest_disordCrohn's disease
SAMN05065738health_condition_detailActive Crohn's diseaseR40.50study.descriptionsubjects with active CD
SAMN05065727subject_idR1004R10.85sample.attr.host_subject_idR1004
SAMN05065727timepoint_labelpre-FMTR10.85sample.attr.time_pointpre-FMT
Sequencing

53 runs over 53 samples · mean 4.80 Gbp per run (median 4.66 Gbp, total 254.49 Gbp; 53 runs with a base count) · layout PAIRED 53 · platform ILLUMINA 53 · models Illumina HiSeq 2500 (53) · 92% of runs with a Sandpiper profile · first public 2016-05-31

Authors (40)

Liu H first · Wang HH last · Elmassry MM first · Sugihara K · Chankhamjon P · Kim Y · Camacho FR · Wang S · Sugimoto Y · Chatterjee S · Chen LA · Kamada N · Donia MS last · Ji S first · Ahmad F · Peng B · Yang Y · Su M · Zhao X · Vatanen T last · Li L first · Liu Z · Qin J · Xiong G · Yang C · Cai F · Huang J last · Garcia-Guevara F first · Resink T · Clasen F · Uhlén M · Achour A · Shoaie S last · Mizrahi I first · Zorea A · Pellow D · Levin L · Pilosof S · Friedman J · Shamir R last

Downloads

PRJNA321058.csv.gz (2.3 KB) · parquet (71.0 KB) — all 53 samples, every field with route and confidence · PRJNA321058_determinations.csv.gz (2.0 KB) — 261 evidence rows

Samples (53 · every field this project has values for · hover a cell for its source)
Loading the sample table…